ARCHIVES

FDA, NCI Remain At Odds Over Drug approval Guidelines Despite Reconciliation Discussion

This article is from The Cancer Letter archive.

Vol. 13 No. 39 | October 9, 1987

Download PDF Visit The Full Archive

Related Articles

In Brief: The Children’s Oncology Group Is Name for Pediatric Trials Groups In Merger

June 25, 1999

DCT Board Approves Concepts For New RFA, New And Recompeting Contracts

June 18, 1982

In Brief: Chabner Names DCT Acting Director, Schepartz Returns To Deputy Job; GM Winners Announced

July 3, 1981

LeMaistre Succeeds Lee Clark As Head Of U. Texas Center

March 10, 1978

Administration Plans to Stop Paying Advisors; NIH, HHS to Make Protest

May 6, 1983

Southern Gets Two More Contracts Totaling 44.5 Million From NCI

June 14, 1974